Evidence map›Paper›PMID 41745525›Full record

ArticleJournal of functional biomaterials2026

Evaluation of Antimicrobials Incorporated into Artificial Saliva: Analysis Against

Camila Alves Carneiro, Fenelon Martinho Lima Pontes, Karin Hermana Neppelenbroek, Rodrigo França, Vinicius Carvalho Porto

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of functional biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Camila Alves CarneiroDepartment of Prosthodontics and Periodontics, Dental School of Bauru, University of São Paulo, Bauru 17000-000, SP, Brazil.ORCID 0000-0003-0211-2957
Fenelon Martinho Lima PontesDepartment of Chemistry, Sao Paulo State University (UNESP), Bauru 17033-360, SP, Brazil.ORCID 0000-0001-6086-5303
Karin Hermana NeppelenbroekDepartment of Prosthodontics and Periodontics, Dental School of Bauru, University of São Paulo, Bauru 17000-000, SP, Brazil.
Rodrigo FrançaDental Materials Research Lab, Department of Restorative Dentistry, Dr. Gerald Niznick College of Dentistry, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.ORCID 0000-0003-2905-3803
Vinicius Carvalho PortoDepartment of Prosthodontics and Periodontics, Dental School of Bauru, University of São Paulo, Bauru 17000-000, SP, Brazil.ORCID 0000-0002-6609-9934

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Saliva is essential for maintaining oral health, and conditions like hyposalivation increase the risk of diseases. To address this, artificial saliva (AS) formulations incorporated with antimicrobials have been proposed. This study aimed to evaluate the antimicrobial activity and determine the minimum inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) of AS formulations containing nystatin (Nys), chlorhexidine diacetate 98% (Chx), and silver nanoparticles (AgNp) against

Indexed as

antimicrobialsartificial salivaCandida albicansnanoparticles

Identifiers

PMID41745525
PMCPMC12941478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.